Incidence of Acute Kidney Injury-Associated Mortality in Hospitalized Children: A Systematic Review and Meta-Analysis Publisher Pubmed



Zarei H¹ ; Azimi A¹ ; Ansarian A¹ ; Raad A¹ ; Tabatabaei H¹ ; Roshdi Dizaji S¹ ; Saadatipour N¹ ; Dadras A¹ ; Ataei N² ; Hosseini M^{3, 4} ; Yousefifard M¹ Show Affiliations
Source: BMC Nephrology Published:2025

Abstract

Background: Acute kidney injury (AKI) is a significant health concern in hospitalized children and is associated with increased mortality. However, the true burden of AKI-associated mortality in pediatric populations remains unclear. Objective: To determine the pooled incidence of mortality independently associated with AKI in hospitalized children globally. Data sources: Medline and Embase were searched for studies published by March 2024. Study eligibility criteria: The inclusion criteria encompassed observational studies involving hospitalized pediatric patients (< 18 years old) with AKI. Only studies that identified AKI as an independent risk factor for increased mortality in multivariate analysis were considered. Study appraisal and synthesis methods: Studies with at least 100 AKI patients were included in the meta-analysis. Two authors extracted data on the study and patients’ characteristics and mortality across AKI stages and assessed the risk of bias. We used a random-effects meta-analysis to generate pooled estimates of mortality. Results: Analysis of 60 studies including 133,876 children with AKI revealed a pooled in-hospital mortality rate of 18.27% (95% CI: 14.89, 21.65). Mortality increased with AKI severity; 8.19% in stage 1, 13.44% in stage 2, and 27.78% in stage 3. Subgroup analyses showed no significant differences across geographical regions, income levels, or AKI definition criteria. The pooled post-discharge mortality rate was 6.84% (95% CI: 5.86, 7.82) in a 1–9-year follow-up period. Conclusions: This meta-analysis demonstrates a substantial global burden of AKI-associated mortality in hospitalized children, with higher mortality rates in more severe AKI stages. These findings highlight the critical need for early detection and intervention strategies in pediatric AKI management. Clinical trial number: Not applicable. © The Author(s) 2025.